HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cosmetics industry should be heedful of FDA commissioner choice -- CTFA counsel Hutt.

This article was originally published in The Rose Sheet

Executive Summary

COSMETICS INDUSTRY SHOULD BE HEEDFUL OF FDA COMMISSIONER CHOICE, recognizing that FDA is "still the single most important federal regulatory agency for our industry," Peter Barton Hutt of the Washington, D.C. law firm Covington & Burling said at the Cosmetic, Toiletry and Fragrance Association's annual meeting in Boca Raton, Fla. Feb. 28. He noted that the industry was "very fortunate" under former FDA Commissioner David Kessler's tenure; in the six years he headed the agency, he "never once singled out our industry for attack nor focused on our cosmetic products.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003872

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel